ArthVani
markets

Akums Drugs and ABSL AMC in Focus: Analysts See Gains Despite Market Dips

By Arth Vani Desk ยท 2026-07-22

While broader Indian markets faced pressure due to global uncertainty, technical analysts have identified potential upside in Akums Drugs and Aditya Birla Sun Life AMC. Both stocks show strong breakout signals and rising trading volumes despite the cautious sentiment ahead of US inflation data.

Key takeaways

While broader Indian markets faced pressure due to global uncertainty, technical analysts have identified potential upside in Akums Drugs and Aditya Birla Sun Life AMC. Both stocks show strong breakout signals and rising trading volumes despite the cautious sentiment ahead of US inflation data.

Global Cues Dampen Domestic Sentiment

Indian equity markets experienced a sluggish session as investors remained on the sidelines ahead of critical macroeconomic data from the United States. The cautious atmosphere was driven by upcoming US inflation figures, which often dictate the direction of global interest rates and foreign fund flows into emerging markets like India.

Despite this overarching weakness in the benchmarks, the mid-cap and specific sectoral spaces are showing signs of life. Market experts suggest that while the 'top-down' view remains murky, a 'bottom-up' approach focusing on individual stock momentum could provide opportunities for retail investors.

Akums Drugs: Technical Breakout Confirmed

Akums Drugs has emerged as a top pick for the upcoming trading sessions. After a period of consolidation, the stock has witnessed a decisive technical breakout. This movement is backed by a significant surge in trading volumes, suggesting that institutional or high-net-worth investors may be taking positions.

Momentum indicators, such as the Relative Strength Index (RSI), are trending upwards, signaling that the stock has moved out of its recent lull. For retail investors, this typically indicates a window where the price action is supported by actual buying pressure rather than mere speculation.

ABSL AMC: Momentum Building

Similarly, Aditya Birla Sun Life AMC (ABSL AMC) is showing strong technical characteristics. The stock has cleared key resistance levels, supported by improving momentum indicators. Analysts noted that the Asset Management Company (AMC) sector has been seeing renewed interest as domestic systematic investment plan (SIP) inflows continue to hit record highs in India.

The technical setup for ABSL AMC suggests that the stock is entering a phase of price discovery on the higher side. With the broader market being volatile, stocks showing independent strength like ABSL AMC often become safe havens for short-to-medium-term traders.

Conclusion for Retail Investors

While the shadow of US macro data looms over the Nifty and Sensex, the individual charts of Akums Drugs and ABSL AMC tell a different story. For those looking to navigate the current volatility, these stocks represent a blend of volume-backed breakouts and positive price momentum. However, it is essential to maintain strict stop-losses given the unpredictable nature of the current global financial environment.

Investment in the securities market is subject to market risks. Read all the related documents carefully before investing. This content is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security.

Frequently asked questions

Why are Indian markets facing pressure?

Indian equity markets are experiencing sluggishness due to investor caution ahead of crucial US inflation data. This data often influences global interest rates and foreign fund flows into emerging markets like India.

What is the technical outlook for Akums Drugs?

Akums Drugs has shown a decisive technical breakout after a consolidation phase. This breakout is supported by a significant surge in trading volumes and upward trending momentum indicators like the RSI.

What factors are driving interest in ABSL AMC?

ABSL AMC is demonstrating strong technical characteristics, clearing key resistance levels with improving momentum. The broader AMC sector is also seeing renewed interest due to record domestic systematic investment plan (SIP) inflows.

Are there specific opportunities despite market dips?

Yes, market experts suggest focusing on individual stock momentum using a 'bottom-up' approach. Akums Drugs and ABSL AMC are identified as potential opportunities due to their strong technical signals.

What is the recommended approach for retail investors?

Retail investors can consider Akums Drugs and ABSL AMC for their volume-backed breakouts and positive price momentum. However, maintaining strict stop-losses is crucial due to the current unpredictable global financial environment.

Source: Economictimes
Investments are subject to market risks. This article is for informational purposes only and not financial advice.